[{"NetIncomeLossConverted_2_Q2_USD":-224076000.0,"NetIncomeLossConverted_1_Q2_USD":-21465000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":-166378000.0,"CommonStockSharesOutstanding_0_Q2_shares":66196000.0,"StockholdersEquity_0_Q2_USD":1682031000.0,"EarningsPerShareBasic_1_Q2_USD":-0.36,"EarningsPerShareBasic_2_Q2_USD":-3.86,"Assets_0_Q2_USD":2107790000.0,"CommonStockSharesConverted_0_Q2_shares":66196000.0,"RevenuesConverted_1_Q2_USD":198890000.0,"RevenuesConverted_2_Q2_USD":220753000.0,"Ticker":"BLUE","CIK":"1293971","name":"BLUEBIRD BIO, INC.","OfficialName":"bluebird bio Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"301448421.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200805"}]